Loading...
Loading...
Application UK00801482014 · Registered
| Application Number | UK00801482014 |
| Status | Registered |
| Owner | Mallinckrodt Pharmaceuticals Ireland Limited |
| Filed | 2019-04-03 |
| Registered | 2020-01-14 |
| Renewal Due | 2029-04-03 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. Sonorant is currently a registered UK trademark, with renewal due on 2029-04-03. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation.
Medical devices; medical apparatus; medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; devices incorporating prefilled syringe containing injectable pharmaceuticals for manual injection.
Custom manufacturing services for pharmaceuticals and active pharmaceutical ingredients.
Training, service and educational support in the fields of pharmaceuticals and medical devices.
Scientific research services for medical purposes.
'Sonorant' is a registered trademark on the UK IPO register, owned by Mallinckrodt Pharmaceuticals Ireland Limited. The application (UK00801482014) was filed on 3 April 2019 and registered on 14 January 2020. The registration is set to expire on 3 April 2029.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 40 (treatment of materials & manufacturing services); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services).
The trademark is represented by Cozen O'Connor LLP.
UK trademark UK00801482014 for the mark 'Sonorant' in Class 5, 10, 40, 41, 42 is recorded on the UK IPO register as owned by Mallinckrodt Pharmaceuticals Ireland Limited. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00801482014 for the mark 'Sonorant' as registered.
UK trademark UK00801482014 for the mark 'Sonorant' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 40 (treatment of materials & manufacturing services); Class 41 (education, entertainment & sporting services); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic dis…
UK trademark UK00801482014 for the mark 'Sonorant' was filed at the UK IPO on 3 April 2019 and registered on 14 January 2020.
UK trademark UK00801482014 for the mark 'Sonorant' is currently recorded as valid until 3 April 2029, at which point it will need to be renewed with the UK IPO to remain in force.
Cozen O'Connor LLP is listed as the attorney / representative of record for UK trademark UK00801482014 for the mark 'Sonorant' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "Sonorant" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| SonorantSame applicant | 2046218 | protected | 2019-10-24 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.